In vitro quantitative analysis of Salmonella typhimurium preference for amino acids secreted by human breast tumor
Bacterial therapies have been paid significant attentions by their ability to penetrate deep into the solid tumor tissue and its propensity to naturally accumulate in tumors of living animals. Understanding the actual mechanism for bacteria to target the tumor is therapeutically crucial but is poorly understood. We hypothesized that amino acids released from the specific tumors induced bacteria to those tumors and the experiments for chemotactic response of bacteria toward the cancer secreting amino acids was then performed by using the diffusion based multiple chemical gradient generator constructed by in situ self-assembly of microspheres. The quantitative analysis was carried out by comparison of intensity using green fluorescent protein (GFP) tagged Salmonella typhimurium (S. typhimurium) in the gradient generator, which showed the clear preference to the released amino acids, especially from breast cancer patients. The understanding chemotaxis toward the cancer secreting amino acids is essential for controlling S. typhimurium targeting in tumors and will allow for the development of bacterial therapies.
KeywordsPDMS Microfluidic Device Chemotactic Response Deep Channel Cell Chamber
Bacteria have been considered as an alternative theranostic activities to overcome the chemotherapeutics barrier [1, 2, 3, 4]. The conventional therapy using anticancer drugs, which are capable of diffusing passively, are limited by their inability to penetrate into the tumor tissue and have poor cell susceptibility [1, 5, 6]. Moreover, the chemotherapy can be harmful to other types of normal cells in the process of treating cancer cell with side effects . To date, the bacteria, which have the motile and easy genetic manipulation capability, could overcome the limitations by their ability to penetrate deep into the solid tumor tissue and its propensity to naturally accumulate in tumors of living animals [1, 4]. Especially, Salmonella typhimurium (S. typhimurium) has been drawn significant attentions for the cancer therapies because several bacteria strains, such as Escherichia coli, Serratia marcescens, and Magnetotactic bacteria strains (Magnetospirillum gryphiswaldense strain MSR-1, Magnetospirillum magnetotacticum strain MS-1, Magnetospirillum magneticum strain AMB-1, and Magnetococcus strain MC-1) have complex incubation procedure and drug resistance against antibiotics and pathogenicity in living animals [4, 7]. Recently, a number of researches have shown that the S. typhimurium preferentially accumulate 2000-fold more in tumors than in liver, spleen, lung, heart, and skin [1, 8, 9]. Moreover, because of propensity of S. typhimurium to naturally accumulate in tumors of small living animals, particularly hypoxic tumors, the S. typhimurium for treatment and diagnosis of colorectal and breast cancers has been extensively studied [4, 8, 10, 11, 12].
Although the understanding an actual mechanism for bacteria to target the tumor is therapeutically crucial, the mechanisms of the bacterial motility toward tumors are unclear. Therefore, for further clinical applications, i.e., for effective bacterial therapies, it is important to investigate and clarify the actual mechanism by which bacteria target cancer. One of the possible mechanisms is the positive chemotaxis toward amino acids released from tumors. Tumors are known to possess and release the high concentration of amino acids, such as aspartate, serine, alanine, glutamine, glutamate, and etc., compared with the surrounding normal tissues .
In order to assess the chemotactic preference of S. typhimurium for the breast cancer, the reference values of amino acid concentration in serum from breast cancer patients and healthy donors were sought firstly and among these amino acids, the lowest values of the threshold concentration (concentration of attractant that induces an accumulation of bacteria in the capillary significantly greater than that obtained absence of attractant) were then chosen. Next, the amino acids were introduced simultaneously into the gradient generation device to mimic the surround environment of the tumor. Lastly, the quantitative analysis of S. typhimurium preference for human breast tumor secreting amino acids was performed. We believe that this understanding chemotaxis toward the cancer secreting amino acids is essential for controlling S. typhimurium targeting in tumors and will allow for the development of bacterial therapies.
Fabrication process of PDMS microfluidic channel
In situ formation of microchannel networks using microparticles
Figure 2c shows the time sequence microscopic images for a formation of the microchannel networks using microspheres within the shallow channel, as reported previously [14, 22, 23, 24, 25]. The PDMS device with shallow channel and deep channels (source/sink channel and center chamber) were fabricated as shown in Fig. 2b. The diluted silica microspheres with diameter of 1 μm (Polyscience Inc., Warrington, USA) in 70 % ethanol (v/v) were then introduced into the source channel (deep channel) by capillary pressure. The diluted microspheres at the interface between shallow and deep channel experience a sudden pressure drop, which tries to drag the solution in the deep channel into the shallow channel . The diluted microspheres at the intersection between shallow and source channel (deep channel) experience a sudden pressure drop (ΔP 12 ), which tries to drag the solution in the deep channel into the shallow channel (F shallow ) . When this flow of solution in shallow channel is located at the neck (interface between the shallow channel and the cell chamber i.e., deep channel), the pressure difference (ΔP n ) between inside (P a ) and outside (P 0) the solution is induced and it can be expressed as below :
Preparation of bacteria cells
Engineered attenuated S. typhimurium defective in guanosine 5′-diphosphate-3′-diphosphate (ppGpp) synthesis (ΔppGpp strain) used to express the bacterial luciferase gene lux for generating imaging signals was used in a chemotaxis experiment [14, 30]. Cells were cultured overnight in 5 mL of Luria–Bertani (LB) medium (Fisher, Pittsburgh, PA, USA) supplemented with 50 μg/mL ampicillin and kanamycin at 37 °C in an incubator with shaking at 200 rpm. A 1 % culture of the bacterial solution in LB medium containing ampicillin and kanamycin was prepared. Then, cells were incubated in a shaking incubator (37 °C, 200 rpm) for 3–4 h until the 600 nm optical density (OD600) of the cell culture reached 1.0. Finally, the cells were centrifuged at 3000 rpm at room temperature and resuspended in M9 medium (minimal salt, BD, NJ, USA.) containing the 10−3 M of glucose. M9 medium is used for making minimal media so that it can provide the basic ionic buffering for the cells, and also provide an environment with comfortable osmotic properties. Therefore, bacteria can be grown until they are cultured in LB medium and they can maintain their population in M9 medium. From this, we can suppress an error which resulted from the increase of bacterial populations during reacting with amino acids. Before cells were loaded, the cell chamber was coated for 2 h with Pluronic surfactant (F-127, 1 %, Sigma-Aldrich, St. Louis, MO, USA) to minimize any nonspecific binding between the cells and the glass surface and subsequently rinsed with M9 medium. Finally, the prepared cell suspension was loaded into the cell chamber.
Experimental setup and data analysis
FITC fluorescence dye diluted in M9 medium was used to characterize the proposed microfluidic device. For the amino acids, α-methyl-DL-aspartic acid and l-arginine were purchased from Sigma-Aldrich, USA, and l-seine and l-alanine were purchased from Daejung Chemicals & Metals, Korea. All amino acids were diluted in M9 medium before using as sources for chemoattractant. The fluorescence intensities could be quantitatively assessed from the captured images using ImagePro Plus (MediaCybernetics, Bethesda, MD, USA) software. A precise microsyringe pump (NE-1000, New Era Pump System, USA) was employed to control the flow rate in the source/sink channel through the microtubes. The cells behavior was monitored using an inverted microscope (IX7, Olympus Co., Tokyo, Japan) and images were captured using a CCD camera (CoolSNAP, Photometrices, Tucson, AZ, USA) installed in the microscope. To quantify the cell count, the same method was used as our previously published paper . Briefly, same amounts of drops containing GFP-expressing S. typhimurium with different normalized concentrations were loaded into the open-cylinder type reservoir and the numbers of cells were calibrated by analyzing the fluorescent intensity. Finally, the fluorescent intensities at three different areas in the cell chamber were measured and then converted into the number of cells. For all statistical tests, analysis was performed using SigmaPlot software, and a p value of <0.05 was considered significant. All data is presented as the mean ± the standard error of the mean (SEM).
Results and discussions
The picture of the fabricated PDMS microfluidic channels with microchannel networks membrane (MCNM) and an enlarged microscopic image around the center chamber are shown in Fig. 2d. The source channels and the cell chamber are isolated by the MCNM. In order to characterize the device, the diffusivity of MCNM was tested using fluorescence dye (FITC). First, the base solution (M9 medium) was filled into the whole device. The fluorescence dye was then introduced into the three source channel (90°, 210°, and 330°). Subsequently, the flow rate of 4.0 μL/min was controlled by withdrawing the solution to maintain the concentration. Finally, the stable concentration of FITC was established across the cell chamber in the three different directions because there was no net flow in the cell chamber but there was the diffusion of fluorescence dyes through the MCNM. Figure 2e shows the fluorescence images at the steady-state and Fig. 2f shows one of representative plots of the normalized fluorescence intensity profiles across the cell chamber as a function of time. The steady-state gradients were established within 1 min and were maintained for several minutes. In this paper, the proposed device was suitable for the chemotactic study for bacterial cells because S. typhimurium showed the chemotactic response toward the amino acids within 80 s.
Threshold concentration of amino acid and secreted concentration from health donors and breast cancer patients
Health donorsb (mM)
Breast cancer patientsb (mM)
To confirm this preference, the experiment for the chemotactic response toward the aspartate versus the serine was performed as shown in Fig. 4b. The serine (1.60 mM) and the aspartate (0.17 mM) diluted in M9 medium were injected into the source channel at 90° and 270°, respectively, and the bacterial cells were then loaded into the center chamber. Each concentration of amino acid was the same as breast cancer patients shown in Table 1. Consequently, the quantitatively counted cells data reveals that the aspartate is most sensitive chemoattractant for the S. typhimurium (t tests, n = 6, mean ± SEM, *: <0.001).
Finally, the bacterial preferential behavior against the released aspartate concentration from breast cancer patients and healthy donors were investigated. The aspartate concentrations of 0.11 and 0.17 mM were chosen for health donors and cancer cell patients, respectively . As shown in Fig. 4c, S. typhimurium showed strong positive chemotactic response toward the concentration gradient of aspartate at the cancer patient level (t tests, n = 6, mean ± SEM, *: <0.001). This result shows the possibility that the concentration gradients of released aspartate from tumor can be crucial for targeting the tumor by S. typhimurium. Moreover, these results are reasonable as comparing with in vitro experiment by using tumor cylindroids model and S. typhimurium which individual chemoreceptors were knockout . The results showed that the aspartate receptor initiated chemotaxis toward tumor cylindroids, the serine receptor initiated penetration, and the ribose/galactose receptor directed S. typhimurium toward necrosis. Previously, we demonstrated that the S. typhimurium showed more strong response toward the aspartate than to the ribose/galactose , the results altogether, therefore, the aspartate could be the one of the essential role for targeting S. typhimurium to the specific tumors.
The chemotactic preference of S. typhimurium for the tumor secreting amino acids, especially for the breast cancer was investigated. The candidate amino acids with the specific concentration values from breast cancer patients were introduced simultaneously into the multiple chemicals gradients generator which was constructed by spatially controlled self-assembly of particles in microchannels. After quantitative analyzing the chemotactic motion of S. typhimurium, we could conclude that S. typhimurium has strongest responsive toward the aspartic acid. This understanding chemotactic response to the cancer secreting amino acids will allow the development of bacterial therapies by utilizing the drug producible engineered bacteria or the bacteria-based micro-robot (bacteriobot) [3, 4, 32, 33] as enhancing the speed and precisely controlling the direction of bacteria.
EC designed and fabricated the microfluidic device and carried out experiments as a main author. BM, JL, HC supported fabrication, experiments and analysis the data. JP is a principle investigator in this research. All authors read and approved the final manuscript.
We wish to thank Dr. Seok-Ho Park and Dr. Jung-Joon Min in Chonnam National University for providing bacterial cells and Dr. Jinwon Lee in Sogang University for helping with culturing the bacteria. Also thanks to Cong Wang in Sogang University for preparing the devices. This work was supported by Pioneer Research Center Program (2012-0001032) and a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (NRF-2013R1A1A2073271, NRF-2015R1A2A2A04006181).
The authors declare that they have no competing interests.
- 4.Park SJ, Park SH, Cho S, Kim DM, Lee Y, Ko SY, Hong Y, Choy HE, Min JJ, Park JO, Park S (2013) New paradigm for tumor theranostic methodology using bacteria-based microrobot. Sci Rep 3:3394Google Scholar
- 8.Forbes NS, Munn LL, Fukumura D, Jain RK (2003) Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors. Cancer Res 63:5188–5193Google Scholar
- 9.Mei S, Theys J, Landuyt W, Anne J, Lambin P (2002) Optimization of tumor-targeted gene delivery by engineered attenuated Salmonella typhimurium. Anticancer Res 22:3261–3266Google Scholar
- 20.Mosadegh B, Agarwal M, Tavana H, Bersano-Begey T, Torisawa Y, Morell M, Wyatt MJ, O’Shea KS, Barald KF, Takayama S (2010) Uniform cell seeding and generation of overlapping gradient profiles in a multiplexed microchamber device with normally-closed valves. Lab Chip 10:2959–2964CrossRefGoogle Scholar
- 31.Melton T, Hartman PE, Stratis JP, Lee TL, Davis AT (1978) Chemotaxis of Salmonella typhimurium to amino acids and some sugars. J Bacteriol 133:708–716Google Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.